Exact Mass: 407.1288

Exact Mass Matches: 407.1288

Found 50 metabolites which its exact mass value is equals to given mass value 407.1288, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

gamma-L-Glutamyl-gamma-L-glutamyl-L-methionine

2-Amino-4-[(1-carboxy-3-{[1-carboxy-3-(methylsulphanyl)propyl]-C-hydroxycarbonimidoyl}propyl)-C-hydroxycarbonimidoyl]butanoic acid

C15H25N3O8S (407.1362)


gamma-L-Glutamyl-gamma-L-glutamyl-L-methionine is found in pulses. gamma-L-Glutamyl-gamma-L-glutamyl-L-methionine is isolated from the seeds of Phaseolus radiatus var. typicus. Isolated from the seeds of Phaseolus radiatus variety typicus. gamma-L-Glutamyl-gamma-L-glutamyl-L-methionine is found in pulses.

   

8-Carboxymethyldihydrochelerythrine

2-{17,18-dimethoxy-21-methyl-5,7-dioxa-21-azapentacyclo[11.8.0.0²,¹⁰.0⁴,⁸.0¹⁴,¹⁹]henicosa-1(13),2,4(8),9,11,14(19),15,17-octaen-20-yl}acetic acid

C23H21NO6 (407.1369)


8-Carboxymethyldihydrochelerythrine is found in fruits. 8-Carboxymethyldihydrochelerythrine is an alkaloid reported to occur in Zanthoxylum simulans (Szechuan pepper

   

N-[2-[(2-Oxoazepan-3-yl)carbamoyl]phenyl]-1-benzothiophene-2-carboxamide

N-[2-[(2-Oxoazepan-3-yl)carbamoyl]phenyl]-1-benzothiophene-2-carboxamide

C22H21N3O3S (407.1304)


   

Chrotacumine A

Chrotacumine A

C23H21NO6 (407.1369)


   
   

4,8-dimethoxy-furo[2,3-b]quinolin-7-yl beta-D-glucopyranoside|Glucohaplin|glucohapline|glycohaplopine|O-beta-D-glucopyranosyl-haplopine

4,8-dimethoxy-furo[2,3-b]quinolin-7-yl beta-D-glucopyranoside|Glucohaplin|glucohapline|glycohaplopine|O-beta-D-glucopyranosyl-haplopine

C19H21NO9 (407.1216)


   

8-acetoxydihydrochelerythrine

8-acetoxydihydrochelerythrine

C23H21NO6 (407.1369)


   
   

trazodone hydrochloride

Trazodone hydrochloride (Desyrel)

C19H23Cl2N5O (407.128)


D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017367 - Selective Serotonin Reuptake Inhibitors D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent D049990 - Membrane Transport Modulators Trazodone hydrochloride (AF-1161) is a serotonin receptor antagonist and reuptake inhibitor. Trazodone hydrochloride can be used for the research of major depressive disorder. Trazodone hydrochloride also has potential for sleep disorder research[1].

   
   
   
   

8-Carboxymethyldihydrochelerythrine

2-{17,18-dimethoxy-21-methyl-5,7-dioxa-21-azapentacyclo[11.8.0.0^{2,10}.0^{4,8}.0^{14,19}]henicosa-1,3,8,10,12,14,16,18-octaen-20-yl}acetic acid

C23H21NO6 (407.1369)


   

gamma-L-Glutamyl-gamma-L-glutamyl-L-methionine

2-amino-4-[(1-carboxy-3-{[1-carboxy-3-(methylsulfanyl)propyl]carbamoyl}propyl)carbamoyl]butanoic acid

C15H25N3O8S (407.1362)


   

Ezetimibe Ketone

Ezetimibe Ketone

C24H19F2NO3 (407.1333)


Ezetimibe ketone (EZM-K) is a phase-I metabolite of Ezetimibe. Ezetimibe is a Niemann-Pick C1-like1 (NPC1L1) inhibitor, and is a potent Nrf2 activator. Ezetimibe is a potent cholesterol absorption inhibitor[1][2][3].

   

Fmoc-(R)-3-Amino-4-(2-thienyl)-butyric acid

Fmoc-(R)-3-Amino-4-(2-thienyl)-butyric acid

C23H21NO4S (407.1191)


   

Fmoc-(S)-3-Amino-4-(3-thienyl)-butyric acid

Fmoc-(S)-3-Amino-4-(3-thienyl)-butyric acid

C23H21NO4S (407.1191)


   

(S)-TERT-BUTYL 3-FORMYLPYRROLIDINE-1-CARBOXYLATE

(S)-TERT-BUTYL 3-FORMYLPYRROLIDINE-1-CARBOXYLATE

C24H19F2NO3 (407.1333)


   

(3-(3,4-DIMETHYL-9-OXO-9H-THIOXANTHEN-2- YLOXY)-2-OH-PROPYL)TRI-ME-AMMON CL 97

(3-(3,4-DIMETHYL-9-OXO-9H-THIOXANTHEN-2- YLOXY)-2-OH-PROPYL)TRI-ME-AMMON CL 97

C21H26ClNO3S (407.1322)


   

N,N,N,N-BIS(TETRAMETHYLENE)-O-(1,2-DIHYDRO-2-OXO-1-PYRIDYL)URONIUM HEXAFLUOROPHOSPHATE

N,N,N,N-BIS(TETRAMETHYLENE)-O-(1,2-DIHYDRO-2-OXO-1-PYRIDYL)URONIUM HEXAFLUOROPHOSPHATE

C14H20F6N3O2P (407.1197)


   

FMOC-D,L-5,5,5-TRIFLUOROLEUCINE

FMOC-D,L-5,5,5-TRIFLUOROLEUCINE

C21H20F3NO4 (407.1344)


   

Fmoc-(R)-3-Amino-4-(3-thienyl)-butyric acid

Fmoc-(R)-3-Amino-4-(3-thienyl)-butyric acid

C23H21NO4S (407.1191)


   

Fmoc-(S)-3-Amino-4-(2-thienyl)-butyric acid

Fmoc-(S)-3-Amino-4-(2-thienyl)-butyric acid

C23H21NO4S (407.1191)


   
   

4-[3-(4-Methoxyphenyl)-5-phenyl-3,4-dihydropyrazol-2-yl]benzenesulfonamide

4-[3-(4-Methoxyphenyl)-5-phenyl-3,4-dihydropyrazol-2-yl]benzenesulfonamide

C22H21N3O3S (407.1304)


ML141 (CID-2950007) is a potent, allosteric, selective and reversible non-competitive inhibitor of Cdc42 GTPase. ML141 inhibits Cdc42 wild type and Cdc42 Q61L mutant with EC50s of 2.1 and 2.6 μM, respectively. ML141 shows low micromolar potency and selectivity against other members of the Rho family of GTPases (Rac1, Rab2, Rab7). ML141 do not show cytotoxicity in multiple cell lines[1][2].

   

(2betaOH)-gibberellin28

(2betaOH)-gibberellin28

C20H23O9-3 (407.1342)


   

7-(4-chlorophenyl)-2-methyl-5-oxo-4-phenyl-4,6,7,8-tetrahydro-1H-quinoline-3-carboxylic acid methyl ester

7-(4-chlorophenyl)-2-methyl-5-oxo-4-phenyl-4,6,7,8-tetrahydro-1H-quinoline-3-carboxylic acid methyl ester

C24H22ClNO3 (407.1288)


   

5-[4-[Methyl-[(3-methyl-2-thiophenyl)methyl]amino]-6-quinazolinyl]-2-furancarboxylic acid ethyl ester

5-[4-[Methyl-[(3-methyl-2-thiophenyl)methyl]amino]-6-quinazolinyl]-2-furancarboxylic acid ethyl ester

C22H21N3O3S (407.1304)


   

maremycin G

maremycin G

C22H21N3O3S (407.1304)


An indole alkaloid with formula C22H21N3O3S. It is a natural product synthesized by an NRPS/PKS system in Streptomyces sp. B917 and exhibits antifungal properties.

   
   
   
   

2-amino-4-({1-[(carboxymethyl)-C-hydroxycarbonimidoyl]-2-[(3-hydroxy-2-methyl-4-oxobutan-2-yl)sulfanyl]ethyl}-C-hydroxycarbonimidoyl)butanoic acid

2-amino-4-({1-[(carboxymethyl)-C-hydroxycarbonimidoyl]-2-[(3-hydroxy-2-methyl-4-oxobutan-2-yl)sulfanyl]ethyl}-C-hydroxycarbonimidoyl)butanoic acid

C15H25N3O8S (407.1362)


   

2-amino-4-({1-[(carboxymethyl)-C-hydroxycarbonimidoyl]-2-[(3-hydroxy-3-methyl-1-oxobutan-2-yl)sulfanyl]ethyl}-C-hydroxycarbonimidoyl)butanoic acid

2-amino-4-({1-[(carboxymethyl)-C-hydroxycarbonimidoyl]-2-[(3-hydroxy-3-methyl-1-oxobutan-2-yl)sulfanyl]ethyl}-C-hydroxycarbonimidoyl)butanoic acid

C15H25N3O8S (407.1362)


   

N-[2-[(2-Oxoazepan-3-yl)carbamoyl]phenyl]-1-benzothiophene-2-carboxamide

N-[2-[(2-Oxoazepan-3-yl)carbamoyl]phenyl]-1-benzothiophene-2-carboxamide

C22H21N3O3S (407.1304)


   

TP003

TP003

C23H16F3N3O (407.1245)


TP003 is a non-selective benzodiazepine site agonist with EC50s of 20.3, 10.6, 3.24, 5.64 nM for α1β2γ2, α2β3γ2, α3β3γ2, α5β2γ2, respectively. TP003 induces anxiolysis via α2GABAA receptors[1].

   

{17,18-dimethoxy-21-methyl-5,7-dioxa-21-azapentacyclo[11.8.0.0²,¹⁰.0⁴,⁸.0¹⁴,¹⁹]henicosa-1(13),2,4(8),9,11,14,16,18-octaen-20-yl}acetic acid

{17,18-dimethoxy-21-methyl-5,7-dioxa-21-azapentacyclo[11.8.0.0²,¹⁰.0⁴,⁸.0¹⁴,¹⁹]henicosa-1(13),2,4(8),9,11,14,16,18-octaen-20-yl}acetic acid

C23H21NO6 (407.1369)


   

(5s,6s)-1',5-dimethyl-2-[(methylsulfanyl)methyl]-4,5,7,8-tetrahydrospiro[cyclopenta[f]quinoxaline-6,3'-indole]-2',3,9-trione

(5s,6s)-1',5-dimethyl-2-[(methylsulfanyl)methyl]-4,5,7,8-tetrahydrospiro[cyclopenta[f]quinoxaline-6,3'-indole]-2',3,9-trione

C22H21N3O3S (407.1304)


   

9-hydroxy-5,14-dimethyl-7-oxo-4,12-dioxa-14-azatetracyclo[11.3.1.0²,¹¹.0³,⁸]heptadeca-2,5,8,10-tetraen-16-yl benzoate

9-hydroxy-5,14-dimethyl-7-oxo-4,12-dioxa-14-azatetracyclo[11.3.1.0²,¹¹.0³,⁸]heptadeca-2,5,8,10-tetraen-16-yl benzoate

C23H21NO6 (407.1369)


   

2-({4,8-dimethoxyfuro[2,3-b]quinolin-7-yl}oxy)-6-(hydroxymethyl)oxane-3,4,5-triol

2-({4,8-dimethoxyfuro[2,3-b]quinolin-7-yl}oxy)-6-(hydroxymethyl)oxane-3,4,5-triol

C19H21NO9 (407.1216)


   

(2s,3s,4s,5s,6r)-2-({4,8-dimethoxyfuro[2,3-b]quinolin-7-yl}oxy)-6-(hydroxymethyl)oxane-3,4,5-triol

(2s,3s,4s,5s,6r)-2-({4,8-dimethoxyfuro[2,3-b]quinolin-7-yl}oxy)-6-(hydroxymethyl)oxane-3,4,5-triol

C19H21NO9 (407.1216)


   

(2s,3r,4s,5s,6r)-2-({4,8-dimethoxyfuro[2,3-b]quinolin-7-yl}oxy)-6-(hydroxymethyl)oxane-3,4,5-triol

(2s,3r,4s,5s,6r)-2-({4,8-dimethoxyfuro[2,3-b]quinolin-7-yl}oxy)-6-(hydroxymethyl)oxane-3,4,5-triol

C19H21NO9 (407.1216)


   

(20s)-17,18-dimethoxy-21-methyl-5,7-dioxa-21-azapentacyclo[11.8.0.0²,¹⁰.0⁴,⁸.0¹⁴,¹⁹]henicosa-1(13),2,4(8),9,11,14,16,18-octaen-20-yl acetate

(20s)-17,18-dimethoxy-21-methyl-5,7-dioxa-21-azapentacyclo[11.8.0.0²,¹⁰.0⁴,⁸.0¹⁴,¹⁹]henicosa-1(13),2,4(8),9,11,14,16,18-octaen-20-yl acetate

C23H21NO6 (407.1369)


   

(1s,13s,16s)-9-hydroxy-5,14-dimethyl-7-oxo-4,12-dioxa-14-azatetracyclo[11.3.1.0²,¹¹.0³,⁸]heptadeca-2,5,8,10-tetraen-16-yl benzoate

(1s,13s,16s)-9-hydroxy-5,14-dimethyl-7-oxo-4,12-dioxa-14-azatetracyclo[11.3.1.0²,¹¹.0³,⁸]heptadeca-2,5,8,10-tetraen-16-yl benzoate

C23H21NO6 (407.1369)


   

5,6-dimethoxy-4,7-bis(4-methoxyphenyl)-1,3-benzothiazole

5,6-dimethoxy-4,7-bis(4-methoxyphenyl)-1,3-benzothiazole

C23H21NO4S (407.1191)


   

(1r,13r,16s)-9-hydroxy-5,14-dimethyl-7-oxo-4,12-dioxa-14-azatetracyclo[11.3.1.0²,¹¹.0³,⁸]heptadeca-2,5,8,10-tetraen-16-yl benzoate

(1r,13r,16s)-9-hydroxy-5,14-dimethyl-7-oxo-4,12-dioxa-14-azatetracyclo[11.3.1.0²,¹¹.0³,⁸]heptadeca-2,5,8,10-tetraen-16-yl benzoate

C23H21NO6 (407.1369)


   

(5s)-1',5-dimethyl-2-[(methylsulfanyl)methyl]-4,5,7,8-tetrahydrospiro[cyclopenta[f]quinoxaline-6,3'-indole]-2',3,9-trione

(5s)-1',5-dimethyl-2-[(methylsulfanyl)methyl]-4,5,7,8-tetrahydrospiro[cyclopenta[f]quinoxaline-6,3'-indole]-2',3,9-trione

C22H21N3O3S (407.1304)


   

[(20r)-17,18-dimethoxy-21-methyl-5,7-dioxa-21-azapentacyclo[11.8.0.0²,¹⁰.0⁴,⁸.0¹⁴,¹⁹]henicosa-1(13),2,4(8),9,11,14,16,18-octaen-20-yl]acetic acid

[(20r)-17,18-dimethoxy-21-methyl-5,7-dioxa-21-azapentacyclo[11.8.0.0²,¹⁰.0⁴,⁸.0¹⁴,¹⁹]henicosa-1(13),2,4(8),9,11,14,16,18-octaen-20-yl]acetic acid

C23H21NO6 (407.1369)


   

17,18-dimethoxy-21-methyl-5,7-dioxa-21-azapentacyclo[11.8.0.0²,¹⁰.0⁴,⁸.0¹⁴,¹⁹]henicosa-1(13),2,4(8),9,11,14,16,18-octaen-20-yl acetate

17,18-dimethoxy-21-methyl-5,7-dioxa-21-azapentacyclo[11.8.0.0²,¹⁰.0⁴,⁸.0¹⁴,¹⁹]henicosa-1(13),2,4(8),9,11,14,16,18-octaen-20-yl acetate

C23H21NO6 (407.1369)


   

1',5-dimethyl-2-[(methylsulfanyl)methyl]-4,5,7,8-tetrahydrospiro[cyclopenta[f]quinoxaline-6,3'-indole]-2',3,9-trione

1',5-dimethyl-2-[(methylsulfanyl)methyl]-4,5,7,8-tetrahydrospiro[cyclopenta[f]quinoxaline-6,3'-indole]-2',3,9-trione

C22H21N3O3S (407.1304)